There are plenty of people taking fluvoxamine already, which acts as a natural experiment. After a few thousand hospitalizations, this effect size would have been obvious (ie. March 2020). At that point, a double-blind study could have been run, which (if done in a city with many infections) could have given results within weeks.
What bit of health research dropped the ball on this?